LLY
Eli Lilly · NYSE · USA
Cap tier
Mega
Approx cap
$700.0B
Bull scenarios
2
Adverse scenarios
0
Other links
0
Modeled impact
unknown
0 explicit links; 2 public links lack move; 0 lack probability
Bull scenarios (2)
Predictions where this ticker benefits
| Pred | Role | Domain | Prediction | Predictor | Current | Move | Impact | Status |
|---|---|---|---|---|---|---|---|---|
| COD_BIO_002 | multi_vector | Biotech/Longevity | An AI-designed Isomorphic or peer drug enters or completes Phase 1 by end 2027 | Codex Research Pack | 50.0% | unknown | unknown | pending |
| COD_BIO_001 | multi_vector | Biotech/Longevity | FDA finalizes or materially advances AI-for-drug-submission guidance by end 2026 | Codex Research Pack | 46.6% | unknown | unknown | pending |
Adverse scenarios (0)
Predictions where this ticker is displaced
| Pred | Domain | Prediction | Predictor | Current | Move | Impact | Mechanism |
|---|---|---|---|---|---|---|---|
| No adverse scenarios | |||||||